Drug Profile
Research programme: anticancer therapeutics - Institute for Cancer Prevention/Integrated BioPharma
Latest Information Update: 21 Jul 2010
Price :
$50
*
At a glance
- Originator Institute for Cancer Prevention; Integrated BioPharma
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 06 Dec 2005 INB:Biotechnologies and City of Hope Cancer Center have entered into an agreement to conduct a phase I trial with Phytosel®
- 12 Jan 2004 Preclinical trials in Cancer in USA (unspecified route)